Ruling hammers Chiron stock
519784
Chiron Corp. shares plunged more than 16 percent Tuesday after it said the entire stockpile of flu vaccine it made overseas for the U.S. market will be withheld this winter because British authorities suspended ...
121462
Executives at the Chiron Corporation hedged yesterday about whether the company would be able to return to selling flu vaccine in the United States next year.
134121
When British regulators shut down Chiron Corporationâs (an Emeryville, Calif. biotechnology company) Liverpool, England factory on Tuesday, Oct. 5, citing concerns about bacterial contamination, they cut
244619
The House of Representatives Committee on Energy and Commerce has subpoenaed Chiron Corp. for certain documents and materials relating to its Fluvirin flu vaccine, the company said in a regulatory filing on Monday.
67567
Chiron (CHIR:Nasdaq - news - research) said Thursday that it had found some problems with the production of its Fluvirin influenza virus vaccine, which will cause a delay in the product&#39;s reaching the market until early October.
581923
It&#39;s not often that the head of a drug company says something that leads newscasts all over the country, but a recent announcement affected millions of consumers and doctors.
425366
Pharmaceutical stocks were in the spotlight Thursday with news that investor Carl Icahn&#39;s was given a green light to buy a sizable chunk of Mylan Laboratories Inc.
264090
NEW YORK - As Wall Street sifts through more than 300 third-quarter earnings reports this week, technology and pharmaceutical stocks will be getting some of the closest scrutiny.    The focus on drug companies results from a recent spate of bad news about Merck & Co...
5323
Shares of Chiron Corp. (CHIR.O: Quote, Profile, Research) fell 7 percent before the market open on Friday, a day after the biopharmaceutical company said it is delaying shipment
444697
SAN FRANCISCO - The nation's supply of vaccine for the impending flu season took a big hit Thursday when Chiron Corp. announced it had found tainted doses in its factory...
70548
Chiron Corp.&#39;s aggressive plan to dominate the US flu-vaccine market is in tatters and the company&#39;s financial future is clouded as the public health crisis it caused continues to mount.
697264
(Washington-NBC) Nov. 17, 2004 - Chiron CEO Howard Pien spoke for the first time since Britain&#39;s MHRA shut his plant down in October and says despite government assurances, &quot;There can be no conclusive assurance
154161
Chiron Corp, one of only two flu jab suppliers to the USA, says that next year&#39;s supply may be in doubt. Health experts and business analysts have been asking for some time that the US authorities add other suppliers to their approvals list.
644960
It began in July: Mylan Laboratories (nyse: MYL - news - people ) announced it would bid $4 billion in stock for King Pharmaceuticals (nyse: KG - news - people ). Investors were less than unanimously thrilled
61771
EMERYVILLE, Calif. A high-tech executive appointed to Chiron&#39;s board of directors last month has resigned from the embattled biotechnology company.
144602
Shares of Radiation Therapy (RTSX:Nasdaq - news - research) were among the worst-performing health and pharmaceutical stocks Thursday after Banc of America Securities initiated coverage with a sell rating.
138973
The announcement came last week: Flu vaccine shortage. Chiron Corporationâs flu vaccine facility in Liverpool, England, had its license suspended for three months by British health regulators because of contamination problems.